Startups
ImCheck Therapeutics

Platform developing new treatments that focus on the butyrophilin family's checkpoint molecules.

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Seedtable Score

Score icon 48

Locations

Company Size

  • 11 to 50

Last Stage Round

Industry

Insights

Total Funding
$102M
Investors